LT3728583T - Neigiama atranka, slopinant sąlygiškai esminius genus - Google Patents
Neigiama atranka, slopinant sąlygiškai esminius genusInfo
- Publication number
- LT3728583T LT3728583T LTEPPCT/EP2018/084463T LTEP2018084463T LT3728583T LT 3728583 T LT3728583 T LT 3728583T LT EP2018084463 T LTEP2018084463 T LT EP2018084463T LT 3728583 T LT3728583 T LT 3728583T
- Authority
- LT
- Lithuania
- Prior art keywords
- inhibition
- counter
- selection
- essential genes
- conditionally essential
- Prior art date
Links
- 108700039887 Essential Genes Proteins 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
- C12Q2521/301—Endonuclease
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17210256 | 2017-12-22 | ||
PCT/EP2018/084463 WO2019121192A1 (en) | 2017-12-22 | 2018-12-12 | Counter-selection by inhibition of conditionally essential genes |
Publications (1)
Publication Number | Publication Date |
---|---|
LT3728583T true LT3728583T (lt) | 2023-06-12 |
Family
ID=60957052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEPPCT/EP2018/084463T LT3728583T (lt) | 2017-12-22 | 2018-12-12 | Neigiama atranka, slopinant sąlygiškai esminius genus |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210017544A1 (lt) |
EP (1) | EP3728583B1 (lt) |
CN (1) | CN111630165B (lt) |
DK (1) | DK3728583T3 (lt) |
FI (1) | FI3728583T3 (lt) |
LT (1) | LT3728583T (lt) |
WO (1) | WO2019121192A1 (lt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112592881B (zh) * | 2021-02-25 | 2021-06-11 | 中国科学院天津工业生物技术研究所 | 用于高效外源蛋白表达和高密度培养的工程枯草芽孢杆菌 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
US5989870A (en) | 1986-04-30 | 1999-11-23 | Rohm Enzyme Finland Oy | Method for cloning active promoters |
DK639689D0 (da) | 1989-12-18 | 1989-12-18 | Novo Nordisk As | Indfoering af dna i celler |
IL103750A0 (en) | 1991-11-14 | 1993-04-04 | Novo Nordisk As | Bacillus promoter |
DK153992D0 (da) | 1992-12-22 | 1992-12-22 | Novo Nordisk As | Metode |
FR2704860B1 (fr) | 1993-05-05 | 1995-07-13 | Pasteur Institut | Sequences de nucleotides du locus cryiiia pour le controle de l'expression de sequences d'adn dans un hote cellulaire. |
DE69523052T2 (de) | 1994-06-03 | 2002-06-20 | Novo Nordisk Biotech, Inc. | Gereinigte myceliophthora laccasen und nukleinsäuren dafür kodierend |
CN1151762A (zh) | 1994-06-30 | 1997-06-11 | 诺沃诺尔迪斯克生物技术有限公司 | 非毒性、非产毒性、非致病性镰孢属表达***及所用启动子和终止子 |
US5882888A (en) | 1995-01-23 | 1999-03-16 | Novo Nordisk A/S | DNA integration by transposition |
WO1996029418A1 (en) | 1995-03-22 | 1996-09-26 | Novo Nordisk A/S | Introduction of dna into bacillus strains by conjugation |
US5955310A (en) | 1998-02-26 | 1999-09-21 | Novo Nordisk Biotech, Inc. | Methods for producing a polypeptide in a bacillus cell |
AU6188599A (en) | 1998-10-26 | 2000-05-15 | Novozymes A/S | Constructing and screening a dna library of interest in filamentous fungal cells |
EP2278016B1 (en) | 1999-03-22 | 2012-09-26 | Novozymes Inc. | Promoter sequences derived from Fusarium Venenatum and uses thereof |
WO2002000907A1 (en) | 2000-06-23 | 2002-01-03 | Novozymes A/S | Method for stable chromosomal multi-copy integration of genes |
WO2005042750A1 (en) | 2003-10-31 | 2005-05-12 | Novozymes A/S | Method for stable gene-amplification in a bacterial host cell |
AU2005230844A1 (en) | 2004-03-31 | 2005-10-20 | Novozymes Biopharma Dk A/S | Methods for producing hyaluronic acid in a bacillus cell |
EP1805296B1 (en) | 2004-10-22 | 2009-09-16 | Novozymes A/S | Stable genomic integration of multiple polynucleotide copies |
EP2029732B1 (en) | 2006-05-31 | 2009-09-23 | Novozymes A/S | Chloramphenicol resistance selection in bacillus licheniformis |
WO2008067423A2 (en) | 2006-11-29 | 2008-06-05 | Novozymes, Inc. | Methods of improving the introduction of dna into bacterial cells |
EP2099818A2 (en) | 2006-11-29 | 2009-09-16 | Novozymes Inc. | Bacillus licheniformis chromosome |
CN102224245B (zh) | 2008-09-30 | 2016-01-13 | 诺维信股份有限公司 | 在丝状真菌细胞中使用阳性和阴性选择性基因的方法 |
CN104619721A (zh) | 2012-09-27 | 2015-05-13 | 诺维信股份有限公司 | 具有改进的转化效率的细菌突变体 |
WO2015065964A1 (en) * | 2013-10-28 | 2015-05-07 | The Broad Institute Inc. | Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof |
JP6688231B2 (ja) * | 2014-06-06 | 2020-04-28 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 標的遺伝子座を修飾するための方法及び組成物 |
US11254933B2 (en) * | 2014-07-14 | 2022-02-22 | The Regents Of The University Of California | CRISPR/Cas transcriptional modulation |
US10676726B2 (en) * | 2015-02-09 | 2020-06-09 | Duke University | Compositions and methods for epigenome editing |
WO2016205745A2 (en) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Cell sorting |
EP3400296A1 (en) * | 2016-01-08 | 2018-11-14 | Novozymes A/S | Genome editing in bacillus host cells |
US11674145B2 (en) * | 2016-01-25 | 2023-06-13 | The Regents Of The University Of California | Pathway integration and expression in host cells |
WO2017136629A1 (en) * | 2016-02-05 | 2017-08-10 | Regents Of The University Of Minnesota | Vectors and system for modulating gene expression |
WO2017191210A1 (en) * | 2016-05-04 | 2017-11-09 | Novozymes A/S | Genome editing by crispr-cas9 in filamentous fungal host cells |
CN109804072A (zh) | 2016-10-25 | 2019-05-24 | 诺维信公司 | 地衣芽孢杆菌中flp介导的基因组整合 |
-
2008
- 2008-12-12 US US16/955,372 patent/US20210017544A1/en active Pending
-
2018
- 2018-12-12 DK DK18814629.4T patent/DK3728583T3/da active
- 2018-12-12 WO PCT/EP2018/084463 patent/WO2019121192A1/en unknown
- 2018-12-12 EP EP18814629.4A patent/EP3728583B1/en active Active
- 2018-12-12 LT LTEPPCT/EP2018/084463T patent/LT3728583T/lt unknown
- 2018-12-12 CN CN201880082411.6A patent/CN111630165B/zh active Active
- 2018-12-12 FI FIEP18814629.4T patent/FI3728583T3/fi active
Also Published As
Publication number | Publication date |
---|---|
FI3728583T3 (fi) | 2023-05-11 |
CN111630165A (zh) | 2020-09-04 |
EP3728583B1 (en) | 2023-03-01 |
WO2019121192A1 (en) | 2019-06-27 |
US20210017544A1 (en) | 2021-01-21 |
CN111630165B (zh) | 2024-07-16 |
EP3728583A1 (en) | 2020-10-28 |
DK3728583T3 (da) | 2023-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287033A (en) | Regulation of nuclease-mediated gene expression | |
HK1246277A1 (zh) | Ask1抑制劑的固體形式 | |
ZA201803436B (en) | Inhibitors of cxcr2 | |
EP3224353C0 (en) | TARGETED REMOVAL OF BACTERIAL GENES | |
EP3551643A4 (en) | LIRAGLUTIDE SUMMARY | |
IL255515A (en) | Identification of genetic changes | |
SI3607068T1 (sl) | Z RNA interferenco posredovano inhibiranje TMPRSS6 | |
ZA201807215B (en) | Amplification of target sequences | |
IL258876B (en) | Treatment of fatty liver associated with low ovulation | |
HK1248139A1 (zh) | Olig2活性的抑制 | |
EP3449001A4 (en) | INHIBITION OF ARNMI MIR-22 BY APT-110 | |
EP3169725A4 (en) | Purification of monomer from recycle polyesters | |
SG10201912370RA (en) | PROMOTER OF Hspa5 GENE | |
HK1231403A1 (zh) | 抑制β 表達的核酸 | |
LT3728583T (lt) | Neigiama atranka, slopinant sąlygiškai esminius genus | |
EP3716973A4 (en) | TUMOR METASTASIS INHIBITION METHODS | |
PL3230300T3 (pl) | Inhibitory do hamowania przerzutów nowotworowych | |
AU2017901956A0 (en) | Inhibition of ferroptosis | |
AU2014904450A0 (en) | Identification of genetic targets |